• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病合并慢性便秘患者肠道神经系统的多巴胺能缺陷

Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

作者信息

Singaram C, Ashraf W, Gaumnitz E A, Torbey C, Sengupta A, Pfeiffer R, Quigley E M

机构信息

Department of Internal Medicine, University of Wisconsin, Madison 52705, USA.

出版信息

Lancet. 1995 Sep 30;346(8979):861-4. doi: 10.1016/s0140-6736(95)92707-7.

DOI:10.1016/s0140-6736(95)92707-7
PMID:7564669
Abstract

Clinical studies suggest that gut disorders are common in Parkinson's disease, but the morphological basis is unknown. Depletion of dopamine-containing neurons in the central nervous system is a basic defect in Parkinson's disease. We compared colonic tissue from 11 patients with advanced Parkinson's disease, 17 with adenocarcinoma (normal tissue was studied), and five who underwent colectomy for severe constipation. Immunohistochemistry was used to stain myenteric and submucosal neurons for dopamine, tyrosine hydroxylase, and vasoactive intestinal polypeptide (VIP). Each class of neurons was quantified as a percentage of the total neuronal population stained for the marker protein gene product 9.5. Nine of the 11 Parkinson's disease patients had substantially fewer dopaminergic myenteric neurons than the other subjects (mean 0.4 [SE 0.2] vs 6.9 [2.3] in controls and 5.7 [2.0] in constipated subjects). There was very little difference between the groups in numbers of tyrosine-hydroxylase and VIP neurons. Two Parkinson's disease patients had similar distributions of all types of neurons, including dopaminergic myenteric neurons, to the controls. High-performance liquid chromatography showed lower levels of dopamine in the muscularis externa (but not mucosa) in four Parkinson's disease patients than in four controls (7.3 [5.1] vs 24.2 [4.6] nmol per g protein), but levels of dopamine metabolites were similar in the two groups. The identification of this defect of dopaminergic neurons in the enteric nervous system in Parkinson's disease may lead to better treatment of colorectal dysfunction in this disease.

摘要

临床研究表明,肠道疾病在帕金森病中很常见,但形态学基础尚不清楚。中枢神经系统中含多巴胺神经元的耗竭是帕金森病的一个基本缺陷。我们比较了11例晚期帕金森病患者、17例腺癌患者(研究正常组织)和5例因严重便秘接受结肠切除术患者的结肠组织。采用免疫组织化学法对肌间神经丛和黏膜下神经元进行多巴胺、酪氨酸羟化酶和血管活性肠肽(VIP)染色。每类神经元被量化为标记蛋白基因产物9.5染色的总神经元群体的百分比。11例帕金森病患者中有9例的多巴胺能肌间神经丛神经元明显少于其他受试者(帕金森病患者组均值为0.4[标准误0.2],对照组为6.9[2.3],便秘患者组为5.7[2.0])。酪氨酸羟化酶神经元和VIP神经元数量在各组之间差异很小。2例帕金森病患者所有类型神经元(包括多巴胺能肌间神经丛神经元)的分布与对照组相似。高效液相色谱法显示,4例帕金森病患者的肌层(而非黏膜)中多巴胺水平低于4例对照组(分别为7.3[5.1]和24.2[4.6]nmol/g蛋白),但两组多巴胺代谢产物水平相似。帕金森病患者肠道神经系统中多巴胺能神经元这一缺陷的发现可能会带来对该疾病结直肠功能障碍更好的治疗方法。

相似文献

1
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.帕金森病合并慢性便秘患者肠道神经系统的多巴胺能缺陷
Lancet. 1995 Sep 30;346(8979):861-4. doi: 10.1016/s0140-6736(95)92707-7.
2
Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation.帕金森病和慢性便秘中神经元血管活性肠肽的下调
Neurogastroenterol Motil. 2017 May;29(5). doi: 10.1111/nmo.12995. Epub 2016 Nov 27.
3
Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.在豚鼠直肠和人结肠的囊泡型乙酰胆碱转运体免疫反应性轴突中选择性表达α-突触核蛋白免疫反应性。
J Comp Neurol. 2013 Feb 15;521(3):657-76. doi: 10.1002/cne.23198.
4
Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD.评估 PD 黏膜下神经丛中的多巴胺能和去甲肾上腺素能神经支配。
J Parkinsons Dis. 2014;4(4):571-6. doi: 10.3233/JPD-140422.
5
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.早期未经治疗的帕金森病患者结肠黏膜下层的α-突触核蛋白。
Mov Disord. 2012 May;27(6):709-15. doi: 10.1002/mds.23838. Epub 2011 Jul 15.
6
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.帕金森病大鼠模型中的肠道动力障碍和肠神经化学变化。
Auton Neurosci. 2012 Aug 16;169(2):77-86. doi: 10.1016/j.autneu.2012.04.005. Epub 2012 May 16.
7
Is pseudomelanosis coli a marker of colonic neuropathy in severely constipated patients?伪膜性结肠黑变病是严重便秘患者结肠神经病变的标志物吗?
Histopathology. 2006 Aug;49(2):132-7. doi: 10.1111/j.1365-2559.2006.02481.x.
8
Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.帕金森病:对肠神经系统中含路易小体神经元的免疫组织化学研究
Acta Neuropathol. 1990;79(6):581-3. doi: 10.1007/BF00294234.
9
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。
Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.
10
Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation.一氧化氮合酶与血管活性肠肽在特发性慢性便秘患者肠神经系统中的分布
Dig Dis Sci. 1995 Nov;40(11):2450-5. doi: 10.1007/BF02063253.

引用本文的文献

1
Fasting and postprandial Ghrelin levels in Parkinson's disease: a systematic review and meta-analysis.帕金森病患者的空腹及餐后胃饥饿素水平:一项系统评价与荟萃分析
NPJ Parkinsons Dis. 2025 Jul 14;11(1):212. doi: 10.1038/s41531-025-01066-0.
2
Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson's disease: Innovative therapies and their translation.短链脂肪酸介导帕金森病中的肠道和中枢神经系统稳态:创新疗法及其转化。
Neural Regen Res. 2026 Mar 1;21(3):938-956. doi: 10.4103/NRR.NRR-D-24-01265. Epub 2025 Apr 29.
3
The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson's disease.
帕金森病进展过程中肠道免疫细胞与肠道α-突触核蛋白之间的相互关系。
Neurol Sci. 2025 Mar 14. doi: 10.1007/s10072-025-08114-w.
4
Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson's disease.帕金森病A53T小鼠模型中随时间变化的胃肠功能和肠神经系统变化评估。
Acta Neuropathol Commun. 2025 Mar 12;13(1):58. doi: 10.1186/s40478-025-01956-7.
5
Physical Activities and Parkinson's Disease Progression: A Two-Sample Mendelian Randomization Study.体育活动与帕金森病进展:一项两样本孟德尔随机化研究。
CNS Neurosci Ther. 2025 Feb;31(2):e70296. doi: 10.1111/cns.70296.
6
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease.药物微生物组学:一个有助于优化帕金森病药物治疗的新领域。
Gut Microbes. 2025 Dec;17(1):2454937. doi: 10.1080/19490976.2025.2454937. Epub 2025 Jan 28.
7
Oral Trehalose Intake Modulates the Microbiota-Gut-Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model.口服海藻糖摄入可调节微生物群-肠道-大脑轴,并在神经核蛋白病小鼠模型中具有神经保护作用。
Nutrients. 2024 Sep 30;16(19):3309. doi: 10.3390/nu16193309.
8
The raphe nuclei are the early lesion site of gastric -synuclein propagation to the substantia nigra.中缝核是α-突触核蛋白向黑质传播的早期病变部位。
Acta Pharm Sin B. 2024 May;14(5):2057-2076. doi: 10.1016/j.apsb.2024.01.015. Epub 2024 Jan 29.
9
Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson's Disease and Aging.帕金森病与衰老中钙蛋白酶激活及Rho-ROCK信号传导的研究进展
Biomedicines. 2024 May 13;12(5):1074. doi: 10.3390/biomedicines12051074.
10
Exploring the nigrostriatal and digestive interplays in Parkinson's disease using dynamic total-body [C]CFT PET/CT.使用动态全身 [C]CFT PET/CT 探索帕金森病中的黑质纹状体和消化系统相互作用。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2271-2282. doi: 10.1007/s00259-024-06638-5. Epub 2024 Feb 23.